Src inhibitors: drugs for the treatment of osteoporosis, cancer or both?

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.21, Iss.12, 2000-12, pp. : 489-495

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancer

By Edwards Joanne

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 5, 2010-05 ,pp. : 605-614

Informa Healthcare

Access to resources Recommend Favorite

Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancer

By Hare Jennifer I. Moase Elaine H. Allen Theresa M.

Journal of Drug Targeting, Vol. 21, Iss. 1, 2013-01 ,pp. : 87-96

Informa Healthcare

Access to resources Recommend Favorite

Non-Covalent Cathepsin K Inhibitors for the Treatment of Osteoporosis

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-02 ,pp. : 355-360

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis inhibitors in the treatment of cancer

By Rhee Jay Hoff Paulo M

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. : 1701-1711

Informa Healthcare

Access to resources Recommend Favorite

Aromatase Inhibitors Evolution as Potential Class of Drugs in the Treatment of Postmenopausal Breast Cancer Women

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 7, 2018-03 ,pp. : 609-621

Bentham Science Publishers

Access to resources Recommend Favorite